Lan-demets Alpha-spending
Lan-DeMets Alpha-Spending is a sequential monitoring boundary method in group-sequential clinical trials that allocates the overall Type I error rate across interim analyses according to a prespecified alpha-spending function derived from Lan and DeMets' stochastic curtailment approach, thereby maintaining trial validity while allowing flexible timing of interim looks.
9
Publications
335
Citations
45
Authors
37
Institutions
Publications per year
2017–2026
0
Parents
9
Charles J. Ryan, Johann S. de Bono, Arturo Molina et al. · Journal of Clinical Oncology · 2012 · 58 citations
Medicine, Oncology, Pharmacology +16
Repeated significance testing in longitudinal clinical trials
Sandra J. Lee · Biometrika · 1996 · 34 citations
1–5 of 9
45
National Heart Lung and Blood Institute, United States
1 publications · 126 citations
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 45
37
Royal Marsden Hospital
London, United Kingdom
1 h-index
1 publications
58 citations
University of California San Diego
San Diego, United States
1 h-index
1 publications
32 citations
Duke Medical Center
Durham, United States
1 h-index
2 publications
64 citations
Dana-Farber Cancer Institute
Boston, United States
1 h-index
1 publications
34 citations
Decision Sciences (United States)
Fort Walton Beach, United States
1 h-index
2 publications
64 citations
Institut Català d'Oncologia
Barcelona, Spain
1 h-index
1 publications
58 citations
Duke University
Durham, United States
1 h-index
3 publications
96 citations
Australasia Paediatric Endocrine Group
Dora Creek, Australia
1 h-index
1 publications
58 citations
1–8 of 37
3 publications · 60 citations
3
h-index
1 publications · 126 citations
1
h-index
1 publications · 27 citations
1
h-index
1 publications · 18 citations
1
h-index
1 publications · 58 citations
1
h-index
1–5